Papers Drug points Thromboembolism associated with the new contraceptive Yasmin BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7383.257 (Published 01 February 2003) Cite this as: BMJ 2003;326:257 Article Related content Metrics Responses Peer review Related articles Research The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study Published: 13 August 2009; BMJ 339 doi:10.1136/bmj.b2921 Editorial Is an EMA review on hormonal contraception and thrombosis needed? Published: 07 March 2013; BMJ 346 doi:10.1136/bmj.f1464 See more The world has made no progress in reducing preventable deaths in pregnancy and childbirth, says UN agency BMJ April 18, 2024, 385 q905; DOI: https://doi.org/10.1136/bmj.q905 Abortion: MPs propose decriminalisation in England and Wales BMJ April 09, 2024, 385 q831; DOI: https://doi.org/10.1136/bmj.q831 US president expands government research into women’s health issues BMJ March 21, 2024, 384 q713; DOI: https://doi.org/10.1136/bmj.q713 Tameside General Hospital must improve its maternity services, says CQC BMJ March 15, 2024, 384 q669; DOI: https://doi.org/10.1136/bmj.q669 NHS rolls out fast tracked immunotherapy for advanced endometrial cancer BMJ March 05, 2024, 384 q557; DOI: https://doi.org/10.1136/bmj.q557 Cited by... Is an EMA review on hormonal contraception and thrombosis needed?Fulltext PDF Computed Tomography of Pulmonary EmbolismFulltext PDF Abstract Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrelFulltext PDF Abstract The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control studyFulltext PDF Abstract